Login / Signup

Prolonged Adrenocortical Blockade Following Discontinuation of Osilodrostat.

Jonathan PoirierFidéline Bonnet-SerranoLouis ThomeretLucas BouysJérôme Bertherat
Published in: European journal of endocrinology (2023)
The finding of this previously undescribed side effect highlights the importance of continuing adrenal function monitoring after Osilodrostat interruption to prevent adrenal crisis in patients at risk.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • public health
  • prognostic factors